These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Entering a new era in the treatment of hepatitis C. Colombo M; Peck-Radosavljevic M Dig Liver Dis; 2014 Dec; 46 Suppl 5():S157. PubMed ID: 25453868 [No Abstract] [Full Text] [Related]
32. Genetic variations in heme oxygenase-1 and chronic hepatitis. Bonkovsky HL; Lambrecht RW; Naishadham D Hepatology; 2010 Jul; 52(1):400-1. PubMed ID: 20232486 [No Abstract] [Full Text] [Related]
33. The efficacy, limitations, and outcomes of our current interferon-based therapies for hepatitis C. Kwo PY; Sozio MS Gastroenterology; 2013 Dec; 145(6):1488-90. PubMed ID: 24409497 [No Abstract] [Full Text] [Related]
34. [Treatment for elderly patients with hepatitis C virus]. Arase Y Nihon Shokakibyo Gakkai Zasshi; 2011 Jul; 108(7):1179-86. PubMed ID: 21737972 [No Abstract] [Full Text] [Related]
36. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2. Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327 [TBL] [Abstract][Full Text] [Related]
37. [Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C]. Irigoien Aleixandre S; Castiella Eguzkira A; Fernández Fernández FJ Rev Esp Enferm Dig; 2003 May; 95(5):364-8. PubMed ID: 12828524 [No Abstract] [Full Text] [Related]
38. Improving anti-HCV therapy. Pol S; Mallet VO Discov Med; 2006 Oct; 6(35):187-90. PubMed ID: 17234140 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of chronic hepatitis C treated with interferon. Hadziyannis SJ; Papatheodoridis GV Ital J Gastroenterol Hepatol; 1999; 31(6):459-61. PubMed ID: 10575562 [No Abstract] [Full Text] [Related]